Can antiplatelet therapy after drug eluting stent become a problem?

Can antiplatelet therapy after drug eluting stent become a problem?

Authors

  • Michele Romano Divisone di Cardiologia. Ospedale Carlo Poma, Mantova

DOI:

https://doi.org/10.7175/cmi.v3i1.556

Keywords:

Drug-eluting stent, Coronary syndromes, Antiplatelet therapy

Abstract

Many clinical trials demonstrate that demonstrate drug-eluting stents (DES) can improve procedural success in patients with acute coronary syndromes, with a remarkable reduction in the rate of restenosis. On the other hand, it has been shown that stenting can also increase the rate of thrombotic complications including stent thrombosis. We describe a case of a 62-yaers-old male with angina. Four weeks after the insertion of a drug-eluting stent, the patients was admitted to our Emergency Department with asthenia.

Downloads

Published

2009-03-15

Issue

Section

Case report
Loading...